Related Experiment Video
Updated: Jun 28, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
[Heart failure and cachexia]
J Y Tabet1, P Meurin, A Ben Driss
1Centre de réadaption cardiaque des Grands Près 27, rue Sainte-Christine, Villeneuve-Saint-Denis. jtabet@free.fr
Abstract:
Cachexia is related to a malnutrition state related to hypercatabolism. Initially described in cancer, it is also related to several chronic diseases including heart failure. Defined by an unintentional weight loss exceeding 7.5% of body mass during more than 6 months, it is presented by the association of nutritional deficiencies, digestive and/or urinary losses as well as metabolic abnormalities causing fat and lean mass loss and is associated to a poor prognosis. The pathophysiology of cachexia and heart failure presented some similarities associating especially neuro-hormonal activation, a cortisol/DHEA ratio imbalance, as well as pro-inflammatory cytokines activation. Currently the treatment of cachexia is mainly preventive, based on ACE-inhibitors and beta-blockers therapy and physical reconditioning. The benefits of hormonal and nutritional substitutes remains to be evidenced.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation